SMTI Sanara MedTech Inc.companySEC Filings & Insider Trading Activity 2026
Latest Sanara MedTech Inc. (SMTI) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 24, 2026, a 10-Q quarterly report filed on May 12, 2026, an 8-K current report filed on June 9, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Sanara MedTech Inc. (SMTI) (SEC CIK 714256), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Annual Reports Archive10-K
AI-powered analysis of Sanara MedTech Inc. (SMTI) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Sanara MedTech Inc. (SMTI) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Sanara MedTech Inc. (SMTI) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2021 | FY2022 | FY2023 | FY2024 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $24.1M | $45.8M | $65.0M | $86.7M |
| Gross Profit | $21.8M | $39.5M | $57.1M | $78.5M |
| Operating Income | — | -$12.2M | -$4.2M | -$6.7M |
| Net Income | — | -$7.9M | -$4.3M | -$9.7M |
| Gross Margin | 90.4% | 86.1% | 87.9% | 90.6% |
| Op. Margin | — | -26.7% | -6.5% | -7.7% |
| Net Margin | — | -17.3% | -6.6% | -11.2% |
| Balance Sheet | ||||
| Total Assets | — | $61.0M | $73.9M | $88.1M |
| Equity | — | $41.8M | $44.8M | $39.4M |
| ROE | — | -19.0% | -9.6% | -24.5% |
Source: XBRL financial data from Sanara MedTech Inc. (SMTI) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jun 9, 2026 | — | — | |
8-K | Jun 4, 2026 | — | — | |
10-Q | May 12, 2026 | Mar 31, 2026 | — | |
8-K | May 11, 2026 | — | — | |
10-K | Mar 24, 2026 | Dec 31, 2025 | — | |
8-K | Mar 24, 2026 | — | — | — |
8-K | Mar 2, 2026 | — | Analysis | — |
8-K | Jan 23, 2026 | — | — | |
8-K | Nov 26, 2025 | — | — | |
10-Q | Nov 12, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 13, 2025 | Jun 30, 2025 | — | |
10-Q | May 14, 2025 | Mar 31, 2025 | — | |
10-K | Mar 25, 2025 | Dec 31, 2024 | Analysis | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
SC 13G | Oct 8, 2024 | — | — | |
10-Q | Aug 12, 2024 | Jun 30, 2024 | — | |
10-Q | May 13, 2024 | Mar 31, 2024 | — | |
10-K | Mar 25, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 13, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 14, 2023 | Jun 30, 2023 | — | |
10-Q | May 15, 2023 | Mar 31, 2023 | — | |
10-K | Mar 20, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 14, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 15, 2022 | Jun 30, 2022 | — | |
10-Q | May 16, 2022 | Mar 31, 2022 | — |
Frequently Asked Questions
What are the latest SMTI SEC filings in 2026?
Sanara MedTech Inc. (SMTI) has filed a 10-K annual report on March 24, 2026, a 10-Q quarterly report on May 12, 2026, an 8-K current report on June 9, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did SMTI file its most recent 10-K annual report?
Sanara MedTech Inc. (SMTI) filed its most recent 10-K annual report on March 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view SMTI 10-Q quarterly reports?
Sanara MedTech Inc. (SMTI)'s most recent 10-Q quarterly report was filed on May 12, 2026. SignalX displays every SMTI 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has SMTI filed recently?
Sanara MedTech Inc. (SMTI)'s most recent 8-K was filed on June 9, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find SMTI insider trading activity (Form 4)?
SignalX aggregates every SMTI Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does SMTI file with the SEC?
Sanara MedTech Inc. (SMTI) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new SMTI filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Sanara MedTech Inc. (SMTI).
What is SMTI's SEC CIK number?
Sanara MedTech Inc. (SMTI)'s SEC CIK (Central Index Key) number is 714256. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 714256 to look up all SMTI filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find SMTI return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Sanara MedTech Inc. (SMTI) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Sanara MedTech Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 88+ filings.